TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 91 filers reported holding TG THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $683,000 | -40.7% | 146,838 | -1.4% | 0.00% | 0.0% |
| Q3 2016 | $1,152,000 | +27.6% | 148,863 | -0.2% | 0.00% | 0.0% |
| Q2 2016 | $903,000 | -24.8% | 149,087 | +5.7% | 0.00% | -50.0% |
| Q1 2016 | $1,201,000 | -18.7% | 140,985 | +13.8% | 0.00% | 0.0% |
| Q4 2015 | $1,478,000 | +18.3% | 123,895 | +0.0% | 0.00% | 0.0% |
| Q3 2015 | $1,249,000 | -40.0% | 123,886 | -1.2% | 0.00% | -33.3% |
| Q2 2015 | $2,081,000 | +60.0% | 125,443 | +49.2% | 0.00% | +50.0% |
| Q1 2015 | $1,301,000 | +5.3% | 84,061 | +7.7% | 0.00% | 0.0% |
| Q4 2014 | $1,236,000 | +68.9% | 78,034 | +13.7% | 0.00% | +100.0% |
| Q3 2014 | $732,000 | +15.1% | 68,610 | +1.3% | 0.00% | 0.0% |
| Q2 2014 | $636,000 | +87.6% | 67,740 | +37.9% | 0.00% | – |
| Q1 2014 | $339,000 | +105.5% | 49,105 | +16.0% | 0.00% | – |
| Q4 2013 | $165,000 | -22.5% | 42,330 | 0.0% | 0.00% | – |
| Q3 2013 | $213,000 | +10.4% | 42,330 | +40.4% | 0.00% | – |
| Q2 2013 | $193,000 | – | 30,148 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 5,229,619 | $74,261,000 | 3.55% |
| RA Capital Management | 2,472,344 | $35,107,000 | 2.69% |
| SENZAR ASSET MANAGEMENT, LLC | 475,918 | $6,758,000 | 2.13% |
| BRIDGER MANAGEMENT, LLC | 2,373,920 | $33,710,000 | 2.04% |
| Opaleye Management Inc. | 274,200 | $3,893,000 | 1.11% |
| Virtus ETF Advisers LLC | 89,920 | $1,277,000 | 1.11% |
| Eversept Partners, LP | 150,000 | $2,130,000 | 0.99% |
| Ghost Tree Capital, LLC | 300,000 | $4,260,000 | 0.86% |
| PURA VIDA INVESTMENTS, LLC | 50,000 | $710,000 | 0.42% |
| HIGHLAND CAPITAL MANAGEMENT LP | 464,391 | $6,595,000 | 0.34% |